An alternative for surgical management of calcific aortic valve stenosis

Sutureless valve implants

Hector I. Michelena, Robert E. Michler, Maurice Enriquez-Sarano, Hartzell V. Schaff, Rakesh M. Suri

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Patients who are candidates for surgical valve replacement (AVR) may benefit from diminished length of cardiopulmonary bypass time. Sutureless valve technology for AVR may facilitate the performance of the operation through smaller incisions, and more expeditiously due to the ability to anchor traditional bovine pericardial prostheses without the need for sutures. We report the first successful US implants of the Sorin PERCEVAL valve as part of the FDA IDE trial. doi: 10.1111/jocs.12333 (J Card Surg 2014;29:490-493)

Original languageEnglish (US)
Pages (from-to)490-493
Number of pages4
JournalJournal of Cardiac Surgery
Volume29
Issue number4
DOIs
StatePublished - 2014

Fingerprint

Aortic Valve Stenosis
Cardiopulmonary Bypass
Surgical Instruments
Sutures
Prostheses and Implants
Technology
Calcification of Aortic Valve

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Medicine(all)

Cite this

An alternative for surgical management of calcific aortic valve stenosis : Sutureless valve implants. / Michelena, Hector I.; Michler, Robert E.; Enriquez-Sarano, Maurice; Schaff, Hartzell V.; Suri, Rakesh M.

In: Journal of Cardiac Surgery, Vol. 29, No. 4, 2014, p. 490-493.

Research output: Contribution to journalArticle

Michelena, Hector I. ; Michler, Robert E. ; Enriquez-Sarano, Maurice ; Schaff, Hartzell V. ; Suri, Rakesh M. / An alternative for surgical management of calcific aortic valve stenosis : Sutureless valve implants. In: Journal of Cardiac Surgery. 2014 ; Vol. 29, No. 4. pp. 490-493.
@article{79afa69deb9d45f1b048e85340c011f9,
title = "An alternative for surgical management of calcific aortic valve stenosis: Sutureless valve implants",
abstract = "Patients who are candidates for surgical valve replacement (AVR) may benefit from diminished length of cardiopulmonary bypass time. Sutureless valve technology for AVR may facilitate the performance of the operation through smaller incisions, and more expeditiously due to the ability to anchor traditional bovine pericardial prostheses without the need for sutures. We report the first successful US implants of the Sorin PERCEVAL valve as part of the FDA IDE trial. doi: 10.1111/jocs.12333 (J Card Surg 2014;29:490-493)",
author = "Michelena, {Hector I.} and Michler, {Robert E.} and Maurice Enriquez-Sarano and Schaff, {Hartzell V.} and Suri, {Rakesh M.}",
year = "2014",
doi = "10.1111/jocs.12333",
language = "English (US)",
volume = "29",
pages = "490--493",
journal = "Journal of Cardiac Surgery",
issn = "0886-0440",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - An alternative for surgical management of calcific aortic valve stenosis

T2 - Sutureless valve implants

AU - Michelena, Hector I.

AU - Michler, Robert E.

AU - Enriquez-Sarano, Maurice

AU - Schaff, Hartzell V.

AU - Suri, Rakesh M.

PY - 2014

Y1 - 2014

N2 - Patients who are candidates for surgical valve replacement (AVR) may benefit from diminished length of cardiopulmonary bypass time. Sutureless valve technology for AVR may facilitate the performance of the operation through smaller incisions, and more expeditiously due to the ability to anchor traditional bovine pericardial prostheses without the need for sutures. We report the first successful US implants of the Sorin PERCEVAL valve as part of the FDA IDE trial. doi: 10.1111/jocs.12333 (J Card Surg 2014;29:490-493)

AB - Patients who are candidates for surgical valve replacement (AVR) may benefit from diminished length of cardiopulmonary bypass time. Sutureless valve technology for AVR may facilitate the performance of the operation through smaller incisions, and more expeditiously due to the ability to anchor traditional bovine pericardial prostheses without the need for sutures. We report the first successful US implants of the Sorin PERCEVAL valve as part of the FDA IDE trial. doi: 10.1111/jocs.12333 (J Card Surg 2014;29:490-493)

UR - http://www.scopus.com/inward/record.url?scp=84904043730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904043730&partnerID=8YFLogxK

U2 - 10.1111/jocs.12333

DO - 10.1111/jocs.12333

M3 - Article

VL - 29

SP - 490

EP - 493

JO - Journal of Cardiac Surgery

JF - Journal of Cardiac Surgery

SN - 0886-0440

IS - 4

ER -